Immunity By Design:
Where biology meets AI to unlock the principles of adaptive immunity.
We bridge tissue immunity, experimental technology, and AI to design interpretable experiments and build models that accelerate therapeutic discovery.
The immune system holds immense therapeutic potential — but decoding its principles demands precision at the intersection of biology and AI.
Experimental technologies are generating high-dimensional, sparse data faster than ever. AI can make sense of it — but only when both tools and experiments are designed specifically for immunology.
At ImmSilico, we help researchers, biotech startups, and policymakers pair their immunological questions with the right experimental platforms and AI approaches, turning complexity into insight.
Why ImmSilico?
Proven Where It Matters
We’ve contributed to breakthrough multidisciplinary studies in Cancer Cell, Nature Medicine, Cell, and Nature — in collaboration with industry and under competitive funding schemes. Our team serves on advisory boards, scientific committees, and major grant review panels.
Mastery at the Intersection
While most consultants focus on either tissue immunity, or experimental technology, or AI — we excel in all three. This prevents costly redesigns when computational assumptions don’t match your data.
Support at Every Stage
From early concept design to troubleshooting mid-project, scaling pilots, or validating feasibility and costs — we provide expert guidance at every step.
Efficient Without Compromising
We deliver solutions quickly and cost-effectively — without sacrificing depth or quality. Every challenge we solve sharpens our expertise.
Learn more about: